Evommune, Inc.: Q3 2025 results
Published 11. 12. 2025, after the market closes. EPS -8,07 $ against an estimate of -11,36.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.